BIIB FY 2015 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2015 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$10.8B+10.9% YoY

Gross Profit

$9.5B88.5% margin

Operating Income

$4.9B45.4% margin

Net Income

$3.5B33.0% margin

EPS (Diluted)

$15.34

Cash Flow

Operating Cash Flow

$3.7B

Free Cash Flow

$3.1B

Stock-Based Comp.

$161M

Balance Sheet

Total Assets

$19.5B

Total Liabilities

$10.1B

Stockholders' Equity

$9.4B

Cash & Equivalents

$1.3B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10.8B	$9.7B	+10.9%
Gross Profit	$9.5B	$8.5B	+11.6%
Operating Income	$4.9B	$4.0B	+23.1%
Net Income	$3.5B	$2.9B	+20.9%